Development and Validation of a Risk Prediction Tool to Identify People with HIV Infection Likely Not to Achieve Viral Suppression.


Journal

AIDS patient care and STDs
ISSN: 1557-7449
Titre abrégé: AIDS Patient Care STDS
Pays: United States
ID NLM: 9607225

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 8 9 2020
Statut: ppublish

Résumé

Identifying people with HIV infection (PHIV), who are at risk of not achieving viral suppression, is important for designing targeted intervention. The aim of this study was to develop and test a risk prediction tool for PHIV who are at risk of not achieving viral suppression after a year of being in care. We used retrospective data to develop an integer-based scoring method using backward stepwise logistic regression. We also developed risk score categories based on the quartiles of the total risk score. The risk prediction tool was internally validated by bootstrapping. We found that nonviral suppression after a year of being in care among PHIV can be predicted using seven variables, namely, age group, race, federal poverty level, current AIDS status, current homelessness status, problematic alcohol/drug use, and current viral suppression status. Those in the high-risk category had about a 23 increase in the odds of nonviral suppression compared with the low-risk group. The risk prediction tool has good discriminative performance and calibration. Our findings suggest that nonviral suppression after a year of being in care can be predicted using easily available variables. In settings with similar demographics, the risk prediction tool can assist health care providers in identifying high-risk individuals to target for intervention. Follow-up studies are required to externally validate this risk prediction tool.

Identifiants

pubmed: 32324484
doi: 10.1089/apc.2019.0224
pmc: PMC7194316
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-165

Subventions

Organisme : NIMHD NIH HHS
ID : S21 MD010683
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD012393
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD012421
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD013563
Pays : United States
Organisme : NIMHD NIH HHS
ID : K01 MD013770
Pays : United States

Références

AIDS Patient Care STDS. 2017 Apr;31(4):167-175
pubmed: 28414260
Clin Infect Dis. 2016 Jan 15;62(2):220-229
pubmed: 26362321
AIDS Patient Care STDS. 2019 Jun;33(6):237-252
pubmed: 31166783
AIDS Patient Care STDS. 2018 Nov;32(11):438-449
pubmed: 30398952
PLoS One. 2018 Jan 2;13(1):e0189973
pubmed: 29293632
J Gen Intern Med. 2009 Sep;24(9):1065-72
pubmed: 19609624
PLoS One. 2018 Apr 3;13(4):e0192785
pubmed: 29614069
Clin Infect Dis. 2016 Mar 1;62(5):648-654
pubmed: 26567263
Pediatr Infect Dis J. 2014 Nov;33(11):1148-55
pubmed: 24945879
J Acquir Immune Defic Syndr. 2013 May 1;63(1):112-9
pubmed: 23392459
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):226-30
pubmed: 24226058
AIDS Care. 2014 Jan;26(1):12-9
pubmed: 23777542
Lancet. 2011 Jul 16;378(9787):208-9
pubmed: 21763923
AIDS Patient Care STDS. 2015 Jan;29 Suppl 1:S27-35
pubmed: 25458205
Medicine (Baltimore). 2016 Mar;95(11):e3051
pubmed: 26986128
AIDS Patient Care STDS. 2019 Oct;33(10):415-424
pubmed: 31390222
MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):85-9
pubmed: 24500286
Medicine (Baltimore). 2016 Mar;95(13):e3171
pubmed: 27043679
AIDS Behav. 2013 Jan;17(1):31-40
pubmed: 23010941
PLoS One. 2013 Dec 18;8(12):e81355
pubmed: 24367482
Clin Infect Dis. 2010 Mar 1;50(5):779-86
pubmed: 20121574
J Gen Intern Med. 2013 May;28(5):622-9
pubmed: 23307396
BMC Infect Dis. 2016 Oct 21;16(1):590
pubmed: 27769246
PLoS Med. 2017 Apr 18;14(4):e1002278
pubmed: 28419097
MMWR Morb Mortal Wkly Rep. 2018 Feb 02;67(4):113-118
pubmed: 29389918
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
J Clin Epidemiol. 2001 Aug;54(8):774-81
pubmed: 11470385
AIDS. 2007 Sep 12;21(14):1867-75
pubmed: 17721094
Int J STD AIDS. 2018 May;29(6):603-610
pubmed: 29334886
Int J Equity Health. 2017 Mar 24;16(1):54
pubmed: 28340589
BMC Med. 2014 Aug 21;12:142
pubmed: 25145556
AIDS. 2007 Mar 30;21(6):685-92
pubmed: 17413689
AIDS Res Ther. 2016 Nov 8;13:35
pubmed: 27826353
AIDS Care. 2016 Nov;28(11):1355-64
pubmed: 27297952
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
Stat Med. 2016 Sep 30;35(22):4056-72
pubmed: 27197622
J Community Health. 2015 Aug;40(4):702-8
pubmed: 25572901
Korean J Radiol. 2016 May-Jun;17(3):339-50
pubmed: 27134523

Auteurs

Merhawi T Gebrezgi (MT)

Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.

Kristopher P Fennie (KP)

Division of Natural Sciences, New College of Florida, Sarasota, Florida, USA.

Diana M Sheehan (DM)

Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.
Center for Research on US Latino HIV/AIDS and Drug Abuse (CRUSADA), Florida International University, Miami, Florida, USA.
Research Centers in Minority Institutions (RCMI), Florida International University, Miami, Florida, USA.

Boubakari Ibrahimou (B)

Department of Biostatistics, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.

Sandra G Jones (SG)

Nicole Wertheim College of Nursing & Health Sciences, Florida International University, Miami, Florida, USA.

Petra Brock (P)

Behavioral Science Research Corporation, Miami, Florida, USA.

Robert A Ladner (RA)

Behavioral Science Research Corporation, Miami, Florida, USA.

Mary Jo Trepka (MJ)

Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.
Research Centers in Minority Institutions (RCMI), Florida International University, Miami, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH